The global market for immunoassay is fragmented in nature with a high number of players engaged in it across the globe, states a new research report by Transparency Market Research.
The rapid development of the healthcare sector and the increasing investments by the leading players, especially for research and development activities, which is estimated to enhance the market development and strengthen the competitive scenario of the market over the next few years.
Moreover, the rising number of partnerships and mergers and the technological developments in this area are projected to enhance the growth of the global immunoassay market in the coming few years.
The leading players operating in the immunoassay market across the globe are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, BioMérieux SA, Becton, Dickinson and Company, DiaSorin S.p.A., Sysmex Corporation, Ortho Clinical Diagnostics, and Danaher Corporation.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=19703As per the research report, in 2017, the global market for immunoassay stood at US$ 16.54 Bn and is estimated to reach a value of US$ 28.61 Bn by the end of 2026.
The North America market for immunoassay is estimated to hold a key share of the market, further followed by Europe.
The strong growth of Europe and North America can be ascribed to the presence of well-established healthcare infrastructure and the development of the biotechnology industry.Growing Adoption of Immunoassay in Oncology to Ensure Market GrowthA significant rise in the incidence of infectious and chronic diseases and the tremendously rising geriatric population are the key factors encouraging the growth of the global immunoassay market in the next few years.
According to the new market research report Immunoassay Market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436Market growth is largely driven by the rising incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions.
Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market.
In contrast, the stringent regulatory scenario and technical hurdles of the immunoassay products may restrict market growth to a certain extent.
The immunoassay market is segmented based on product, technology, specimen, application, end user and region.The global immunoassay market is consolidated.
With a wide distribution network across the globe and a strong product portfolio, it has established itself as one of the leading market players.
The acquisition created its global science and technology innovator company, known as Cytiva.Thermo Fisher Scientific (US) is one of the leading players in the immunoassay market.
The global market for immunoassay is fragmented in nature with a high number of players engaged in it across the globe, states a new research report by Transparency Market Research.
The rapid development of the healthcare sector and the increasing investments by the leading players, especially for research and development activities, which is estimated to enhance the market development and strengthen the competitive scenario of the market over the next few years.
Moreover, the rising number of partnerships and mergers and the technological developments in this area are projected to enhance the growth of the global immunoassay market in the coming few years.
The leading players operating in the immunoassay market across the globe are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, BioMérieux SA, Becton, Dickinson and Company, DiaSorin S.p.A., Sysmex Corporation, Ortho Clinical Diagnostics, and Danaher Corporation.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=19703As per the research report, in 2017, the global market for immunoassay stood at US$ 16.54 Bn and is estimated to reach a value of US$ 28.61 Bn by the end of 2026.
The North America market for immunoassay is estimated to hold a key share of the market, further followed by Europe.
The strong growth of Europe and North America can be ascribed to the presence of well-established healthcare infrastructure and the development of the biotechnology industry.Growing Adoption of Immunoassay in Oncology to Ensure Market GrowthA significant rise in the incidence of infectious and chronic diseases and the tremendously rising geriatric population are the key factors encouraging the growth of the global immunoassay market in the next few years.
According to the new market research report Immunoassay Market is projected to reach USD 39.0 billion by 2026 from USD 28.4 billion in 2021, at a CAGR of 6.6% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436Market growth is largely driven by the rising incidence of chronic and infectious diseases, technological advancements of immunoassay products, and their massive adoptions.
Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market.
In contrast, the stringent regulatory scenario and technical hurdles of the immunoassay products may restrict market growth to a certain extent.
The immunoassay market is segmented based on product, technology, specimen, application, end user and region.The global immunoassay market is consolidated.
With a wide distribution network across the globe and a strong product portfolio, it has established itself as one of the leading market players.
The acquisition created its global science and technology innovator company, known as Cytiva.Thermo Fisher Scientific (US) is one of the leading players in the immunoassay market.